Clinical challenges: Myeloma and concomitant Type 2 Diabetes
Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there wil...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2013-03-01
|
| Series: | International Journal of Hematology-Oncology and Stem Cell Research |
| Subjects: | |
| Online Access: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/463 |
| _version_ | 1797722786864562176 |
|---|---|
| author | Yasar Albushra Abdul Rahiem Ahmed Awad Eltayeb |
| author_facet | Yasar Albushra Abdul Rahiem Ahmed Awad Eltayeb |
| author_sort | Yasar Albushra Abdul Rahiem Ahmed |
| collection | DOAJ |
| description | Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians. |
| first_indexed | 2024-03-12T09:52:28Z |
| format | Article |
| id | doaj.art-aaa830def7394eb6a92c1b141c16abcc |
| institution | Directory Open Access Journal |
| issn | 2008-2207 |
| language | English |
| last_indexed | 2024-03-12T09:52:28Z |
| publishDate | 2013-03-01 |
| publisher | Tehran University of Medical Sciences |
| record_format | Article |
| series | International Journal of Hematology-Oncology and Stem Cell Research |
| spelling | doaj.art-aaa830def7394eb6a92c1b141c16abcc2023-09-02T12:25:02ZengTehran University of Medical SciencesInternational Journal of Hematology-Oncology and Stem Cell Research2008-22072013-03-0171Clinical challenges: Myeloma and concomitant Type 2 DiabetesYasar Albushra Abdul Rahiem Ahmed0Awad Eltayeb1MRCP MRCPS FRSM, Adult Medical oncology, Princess Noorah oncology Center, King Abdulaziz Medical City, National Guard Health Affairs, Saudia Arabia.Ph.D; FRCP FRCPath, (Haematology), Professor of Hematology, King Khalid University, Abha, Saudi Arabia.Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians.https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/463Diabetes mellitusMultiple myeloma |
| spellingShingle | Yasar Albushra Abdul Rahiem Ahmed Awad Eltayeb Clinical challenges: Myeloma and concomitant Type 2 Diabetes International Journal of Hematology-Oncology and Stem Cell Research Diabetes mellitus Multiple myeloma |
| title | Clinical challenges: Myeloma and concomitant Type 2 Diabetes |
| title_full | Clinical challenges: Myeloma and concomitant Type 2 Diabetes |
| title_fullStr | Clinical challenges: Myeloma and concomitant Type 2 Diabetes |
| title_full_unstemmed | Clinical challenges: Myeloma and concomitant Type 2 Diabetes |
| title_short | Clinical challenges: Myeloma and concomitant Type 2 Diabetes |
| title_sort | clinical challenges myeloma and concomitant type 2 diabetes |
| topic | Diabetes mellitus Multiple myeloma |
| url | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/463 |
| work_keys_str_mv | AT yasaralbushraabdulrahiemahmed clinicalchallengesmyelomaandconcomitanttype2diabetes AT awadeltayeb clinicalchallengesmyelomaandconcomitanttype2diabetes |